Usa Eu World Health Usa Eu

EMA starts review of oral Covid drug from Merck

Reading now: 212
www.rte.ie

The EU's medicines watchdog has started a review of an oral Covid medication from the US pharmaceutical firm Merck, raising hopes for an easy-to-administer treatment to reduce serious or deadly cases.

The move, which could eventually lead to authorisation on the European market, comes two weeks after Merck applied for emergency use in the US of the anti-coronavirus drug. "EMA's human medicines committee (CHMP) has started a rolling review of the oral antiviral medicine molnupiravir...

developed by Merck Sharp & Dohme in collaboration with Ridgeback Biotherapeutics for the treatment of Covid-19 in adults," the European Medicines Agency said in a statement.

Read more on rte.ie
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA